• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平和安替比林之间可能存在的药代动力学相互作用的研究。

An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.

作者信息

Edeki T, Johnston A, Turner P

机构信息

Department of Clinical Pharmacology, St. Bartholomew's Hospital, London.

出版信息

Eur J Clin Pharmacol. 1990;39(4):405-7. doi: 10.1007/BF00315420.

DOI:10.1007/BF00315420
PMID:2076727
Abstract

The influence of 2 weeks oral intake of nifedipine (2 x 20 mg) on the oxidative metabolism of antipyrine was investigated in 12 normal volunteers, who had 1050 mg antipyrine solution orally before and after the course of nifedipine. There were no statistically significant differences in the saliva pharmacokinetic parameters of antipyrine on both occassions. However, the metabolite profile of antipyrine in urine showed a significant reduction in the amount of norantipyrine excreted after compared to that before nifedipine administration (16.5 vs 19.6%). This may have implications for drugs that share a similar demethylation pathway with norantipyrine.

摘要

在12名正常志愿者中研究了口服硝苯地平(2×20mg)两周对安替比林氧化代谢的影响,这些志愿者在硝苯地平疗程前后均口服1050mg安替比林溶液。两次测量时安替比林的唾液药代动力学参数无统计学显著差异。然而,与硝苯地平给药前相比,尿液中安替比林的代谢产物谱显示去甲安替比林排泄量显著减少(16.5%对19.6%)。这可能对与去甲安替比林具有相似去甲基化途径的药物有影响。

相似文献

1
An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine.硝苯地平和安替比林之间可能存在的药代动力学相互作用的研究。
Eur J Clin Pharmacol. 1990;39(4):405-7. doi: 10.1007/BF00315420.
2
Antipyrine repeatability and comparison of the powder and capsule formulations.安替比林的可重复性以及粉剂和胶囊剂配方的比较。
Int J Clin Pharmacol Ther. 1995 Feb;33(2):70-5.
3
Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.人体中安替比林不同代谢途径的研究。口服与静脉注射给药以及尿液收集时间的影响。
Eur J Clin Pharmacol. 1982;21(5):433-41. doi: 10.1007/BF00542332.
4
Influence of renal failure on cytochrome P450 activity in hypertensive patients using a "cocktail" of antipyrine and nifedipine.使用安替比林和硝苯地平“鸡尾酒”法研究肾衰竭对高血压患者细胞色素P450活性的影响
Eur J Clin Pharmacol. 1996;50(1-2):83-9. doi: 10.1007/s002280050073.
5
Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine.HMG-CoA还原酶抑制剂阿托伐他汀对安替比林肝脏氧化代谢的影响。
J Clin Pharmacol. 1996 Apr;36(4):356-60. doi: 10.1002/j.1552-4604.1996.tb04212.x.
6
Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Xenobiotica. 1991 Jan;21(1):33-46. doi: 10.3109/00498259109039448.
7
Physical exercise and improvement of liver oxidative metabolism in the elderly.老年人的体育锻炼与肝脏氧化代谢的改善
Eur J Appl Physiol. 2000 Jan;81(1-2):62-6. doi: 10.1007/PL00013798.
8
The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.甲氟喹在人体内的药代动力学:甲氟喹对安替比林代谢无影响。
Br J Clin Pharmacol. 1985 Nov;20(5):469-74. doi: 10.1111/j.1365-2125.1985.tb05099.x.
9
The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits.小脂质体静脉预处理对兔体内安替比林药代动力学及代谢的影响。
J Pharm Pharmacol. 1992 Apr;44(4):366-8. doi: 10.1111/j.2042-7158.1992.tb03624.x.
10
Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.
Eur J Clin Pharmacol. 1985;28(6):681-4. doi: 10.1007/BF00607915.

引用本文的文献

1
The potential of the South African plant Tulbaghia Violacea Harv for the treatment of triple negative breast cancer.南非植物紫花垂笑君子兰治疗三阴性乳腺癌的潜力。
Sci Rep. 2025 Feb 17;15(1):5737. doi: 10.1038/s41598-025-88417-2.

本文引用的文献

1
Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.关于安替比林半衰期、清除率和分布容积之间关系的进一步观察:对用于评估安替比林消除的替代动力学参数的评估。
Clin Pharmacokinet. 1980 May-Jun;5(3):263-73. doi: 10.2165/00003088-198005030-00005.
2
Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.人体内安替比林三种主要氧化代谢物的体内和体外生成速率比较。
Br J Clin Pharmacol. 1981 Dec;12(6):771-7. doi: 10.1111/j.1365-2125.1981.tb01305.x.
3
Nifedipine in unstable angina: a double-blind, randomized trial.
硝苯地平治疗不稳定型心绞痛:一项双盲随机试验
N Engl J Med. 1982 Apr 15;306(15):885-9. doi: 10.1056/NEJM198204153061501.
4
Randomized double-blind comparison of nifedipine and isosorbide dinitrate therapy in variant angina pectoris due to coronary artery spasm.
Am Heart J. 1982 Jan;103(1):44-9. doi: 10.1016/0002-8703(82)90527-0.
5
Pharmacokinetics and metabolism of nifedipine.硝苯地平的药代动力学与代谢
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II18-24. doi: 10.1161/01.hyp.5.4_pt_2.ii18.
6
Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording.硝苯地平片治疗系统性高血压:一项使用连续动态动脉内记录的研究。
Am J Cardiol. 1983 May 1;51(8):1323-7. doi: 10.1016/0002-9149(83)90306-5.
7
Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
Clin Pharmacol Ther. 1984 Jun;35(6):815-21. doi: 10.1038/clpt.1984.118.
8
Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine.血浆、唾液和尿液中安替比林及其主要代谢物(包括4,4'-二羟基安替比林)的高效液相色谱自动测定法
J Chromatogr. 1983 Dec 9;278(2):367-78.
9
Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man.
Biochem Pharmacol. 1984 Nov 15;33(22):3721-4. doi: 10.1016/0006-2952(84)90165-5.
10
Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.硝苯地平片的药代动力学研究。与降压效果的相关性。
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II29-33. doi: 10.1161/01.hyp.5.4_pt_2.ii29.